Prof. Sir Chris Evans
The Cancer Platform
Professor Sir Chris Evans is one of the world's leading biotech entrepreneurs, a scientist and family man, who has spent 36+ years at the forefront of his trade, turning scientific discoveries into products and services that have directly benefited the lives of people around the world. He started his first company, Enzymatix in 1987 where he quickly developed surfactants which went on to save the lives of millions of premature babies by enabling their lungs to open. In 1995, he become an OBE and by 2001 he became the youngest scientist to be knighted for services to bioscience, enterprise and through advisory roles to the UK and global governments. Alongside his wider research, finding more positive outcomes and options for those affected by cancer has always been a focus of Sir Chris’. In 2017 he made it his primary mission to spend significant time, money and resources, investing in and bringing together global expertise to unearth new cancer breakthroughs. This included co-founding the cancer drug development company, Ellipses Pharma alongside Dr Rajan Jethwa, in addition to co-founding the UK charity, The Cancer Awareness Trust with the purpose of building the Cancer Platform. In 2022, Sir Chris launched EDX Medical to focus on creating cancer prevention and diagnostics solutions.